Wang, Tao published the artcileDesign and synthesis of tumor-targeting theranostic drug conjugates for SPECT and PET imaging studies, Quality Control of 359860-27-8, the publication is Bioorganic Chemistry (2018), 458-467, database is CAplus and MEDLINE.
Theranostics will play a significant role in the next-generation chemotherapy. Two novel tumor-targeting theranostic drug conjugates, bearing imaging arms, were designed and synthesized. These theranostic conjugates consist of biotin as the tumor-targeting moiety, a second generation taxoid, SB-T-1214, as a potent anticancer drug, and two different imaging arms for capturing 99mTc for SPECT (single photon emission computed tomog.) and 64Cu for PET (positron emission tomog.). To explore the best reaction conditions for capturing radionuclides and work out the chem. directly applicable to “hot” nuclides, cold chem. was investigated to capture 185Re(I) and 63Cu(II) species as surrogates for 99mTc and 64Cu, resp.
Bioorganic Chemistry published new progress about 359860-27-8. 359860-27-8 belongs to imidazoles-derivatives, auxiliary class Other Aliphatic Heterocyclic,Chiral,Amine,Amide,Ether,Inhibitor, name is N-(2-(2-(2-(2-Aminoethoxy)ethoxy)ethoxy)ethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, and the molecular formula is C15H20O6, Quality Control of 359860-27-8.
Referemce:
https://en.wikipedia.org/wiki/Imidazole,
Imidazole | C3H4N2 – PubChem